154 related articles for article (PubMed ID: 21962092)
41. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
[TBL] [Abstract][Full Text] [Related]
42. Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents.
Shapiro GG; Izu AE; Furukawa CT; Pierson WE; Bierman CW
Chest; 1981 Dec; 80(6):671-5. PubMed ID: 7030652
[TBL] [Abstract][Full Text] [Related]
43. Influence of inhaled corticosteroids on pubertal growth and final height in asthmatic children.
De Leonibus C; Attanasi M; Roze Z; Martin B; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A
Pediatr Allergy Immunol; 2016 Aug; 27(5):499-506. PubMed ID: 26919136
[TBL] [Abstract][Full Text] [Related]
44. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
Skoner DP; Meltzer EO; Milgrom H; Stryszak P; Teper A; Staudinger H
J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
[TBL] [Abstract][Full Text] [Related]
45. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
[TBL] [Abstract][Full Text] [Related]
46. Nebulized flunisolide in infants and young children with asthma: a pilot study.
de Benedictis FM; Martinati LC; Solinas LF; Tuteri G; Boner AL
Pediatr Pulmonol; 1996 May; 21(5):310-5. PubMed ID: 8726156
[TBL] [Abstract][Full Text] [Related]
47. Treatment with inhaled flunisolide.
Edmonds ML; Rowe BH
Chest; 2004 May; 125(5):1961-2; author reply 1962-3. PubMed ID: 15136418
[No Abstract] [Full Text] [Related]
48. Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers.
Nolting A; Sista S; Abramowitz W
Biopharm Drug Dispos; 2001 Dec; 22(9):373-82. PubMed ID: 11870676
[TBL] [Abstract][Full Text] [Related]
49. Inhaled corticosteroids used for the control of asthma in a "real-life" setting do not affect linear growth velocity in prepubertal children.
Erceg D; Nenadic N; Plavec D; Nogalo B; Turkalj M
Med Sci Monit; 2012 Sep; 18(9):CR564-8. PubMed ID: 22936192
[TBL] [Abstract][Full Text] [Related]
50. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
Welch M; Bernstein D; Gross G; Kane RE; Banerji D
Chest; 1999 Nov; 116(5):1304-12. PubMed ID: 10559092
[TBL] [Abstract][Full Text] [Related]
51. Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma.
Slavin RG; Izu AE; Bernstein IL; Blumenthal MN; Bolin JF; Ouellette JJ; Reed CE; Oren J
J Allergy Clin Immunol; 1980 Nov; 66(5):379-85. PubMed ID: 7440855
[TBL] [Abstract][Full Text] [Related]
52. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
53. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
Gillissen A; Richter A; Oster H; Criée CP
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
[TBL] [Abstract][Full Text] [Related]
55. Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis.
Loke YK; Blanco P; Thavarajah M; Wilson AM
PLoS One; 2015; 10(7):e0133428. PubMed ID: 26191797
[TBL] [Abstract][Full Text] [Related]
56. Corticosteroids administered by nebulization to children with bronchial asthma.
Terzano C; Barkai L; Cremonesi G
Adv Ther; 2001; 18(6):253-60. PubMed ID: 11841195
[TBL] [Abstract][Full Text] [Related]
57. Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children.
Piacentini GL; Sette L; Peroni DG; Bonizzato C; Bonetti S; Boner AL
Allergy; 1990 Nov; 45(8):612-6. PubMed ID: 2288396
[TBL] [Abstract][Full Text] [Related]
58. Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group.
Newhouse M; Knight A; Wang S; Newman K
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):313-9. PubMed ID: 10752915
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of bone metabolism after the use of an inhaled glucocorticoid (flunisolide) in patients with moderate asthma.
Hauache OM; Amarante EC; Vieira JG; Faresin SM; Fernandes AL; Jardim JR; Lazaretti-Castro M
Clin Endocrinol (Oxf); 1999 Jul; 51(1):35-9. PubMed ID: 10468963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
